Forget Crispr Therapeutics: This Gene-Editing Pick Attracts
The gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
Stock index values update on scheduled times or upon data arrivals, varying by index and exchange. This piece covers the timing and implications.
22,965 articlesThe gene-editing field is maturing from hype to real profits. This article outlines why a broader set of players coul...
As Anthropic prepares an IPO, history warns that sky-high private valuations rarely translate into smooth public-mark...
Travel stocks rarely move in perfect tandem. This guide weighs Booking Holdings and Marriott International to help yo...
On a day when the market waded through tensions abroad and a stubborn oil rally, energy names bucked the trend. This ...
Citi warns that the stock market frothiest since the global financial crisis has created vulnerabilities, but says pa...
Cineverse is navigating the shifting streaming landscape as it reports 2026 earnings. This guide explains what the nu...
Looking for smart growth amidst market swings? This guide reveals actionable ways to spot stocks double right opportu...
A director at The Cheesecake Factory recently disclosed a sizable stock move. This guide breaks down what that inside...
AI data centers are pushing bandwidth limits, lifting demand for photonics. This report examines five notable players...
Marvell Technology has surged as AI workloads push demand for data-center hardware. This article breaks down the driv...
Walmart faces a pivotal moment as macro headwinds collide with a fast-growing digital ecosystem. This report examines...
Palantir trades sales. Here's a clear-eyed view of why the market pays up for this AI-driven data platform, plus acti...